RE:RE:RE:RE:RE:The Boredlscfa wrote: The phrase you're looking for is "empire building", a purely self-indulgent act by Gagnon.
CZO was always hopeful to build a PGX empire and biopharma company. No Mickey Mouse licensing deal. Shareholders were hopeful too. As CZO's pipeline nears key development milestones and deals it now has $60 million cash, internaitonal infrastructure, a NASDAQ listing, and potential analyst coverage.
The yeast beta glucan immune booster market is worth $1 billion. CZO could have the gold standard in a $1 billion market. The CoQ10 market is $4 billion Gilles noted. CZO blew away the industry gold standard. CZO once talked about a $40 million immune booster plant didn't it? What was the NPV? Imagine the NPV with 100L scale-up completed in coming months.